2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013
08/14/18
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08/09/18
Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals
08/01/18
Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer
07/19/18
Organovo Announces Release Date for Fiscal First-Quarter 2019 Financial Results
05/31/18
Organovo Reports Fiscal Fourth-Quarter and Full-Year 2018 Results; Company Announces Key Goals for Fiscal-Year 2019
05/14/18
Organovo Announces Release Date for Fiscal Fourth-Quarter 2018 Financial Results
05/10/18
Organovo to Present New Preclinical Data for Its Liver Therapeutic Tissue IND-Track Programs at the World Advanced Therapies and Regenerative Medicine Congress
05/03/18
Organovo and Samsara Sciences Partner with New Manufacturing USA Institute
04/24/18
Organovo to Present at 2nd Annual NASH Summit
04/16/18
Organovo Achieves Key Development Milestones for Its Liver Disease and Intestinal Tissue Models
04/12/18
Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™
03/26/18
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
03/15/18
Organovo to Present at H.C. Wainwright Nash Investor Conference
03/08/18
Organovo to Present at 30th Annual ROTH Conference
02/08/18
Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook
01/18/18
Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet
MENU